COYA
Price
$5.86
Change
+$0.15 (+2.63%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
95.5M
81 days until earnings call
SNDX
Price
$9.85
Change
-$0.96 (-8.88%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
930.17M
80 days until earnings call
Interact to see
Advertisement

COYA vs SNDX

Header iconCOYA vs SNDX Comparison
Open Charts COYA vs SNDXBanner chart's image
Coya Therapeutics
Price$5.86
Change+$0.15 (+2.63%)
Volume$200
Capitalization95.5M
Syndax Pharmaceuticals
Price$9.85
Change-$0.96 (-8.88%)
Volume$78.87K
Capitalization930.17M
COYA vs SNDX Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. SNDX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (COYA: $5.71 vs. SNDX: $10.81)
Brand notoriety: COYA and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 65% vs. SNDX: 124%
Market capitalization -- COYA: $95.5M vs. SNDX: $930.17M
COYA [@Biotechnology] is valued at $95.5M. SNDX’s [@Biotechnology] market capitalization is $930.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both COYA and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 2 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 2 bullish, 6 bearish.
  • SNDX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а -2.73% price change this week, while SNDX (@Biotechnology) price change was +20.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

COYA is expected to report earnings on Aug 12, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($930M) has a higher market cap than COYA($95.5M). COYA YTD gains are higher at: -0.349 vs. SNDX (-18.230). COYA has higher annual earnings (EBITDA): -11.33M vs. SNDX (-318.27M). SNDX has more cash in the bank: 516M vs. COYA (31.1M). SNDX has higher revenues than COYA: SNDX (43.7M) vs COYA (9.55M).
COYASNDXCOYA / SNDX
Capitalization95.5M930M10%
EBITDA-11.33M-318.27M4%
Gain YTD-0.349-18.2302%
P/E RatioN/AN/A-
Revenue9.55M43.7M22%
Total Cash31.1M516M6%
Total DebtN/A1.84M-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYASNDX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBGLY13.290.13
+0.99%
Reckitt Benckiser Group Plc.
AMIGY45.530.44
+0.98%
Admiral Group Plc.
LYTHF0.02N/A
N/A
Lytus Technologies Holdings PTV Ltd
EDPFY39.25-0.15
-0.38%
EDP S.A.
GLASF6.00-0.10
-1.64%
Glass House Brands Inc.

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with NTLA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+0.71%
NTLA - COYA
37%
Loosely correlated
+2.83%
KNSA - COYA
36%
Loosely correlated
-0.65%
EYPT - COYA
35%
Loosely correlated
-4.60%
XNCR - COYA
34%
Loosely correlated
+2.26%
SNDX - COYA
34%
Loosely correlated
+1.50%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with KRYS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.50%
KRYS - SNDX
51%
Loosely correlated
N/A
KYMR - SNDX
51%
Loosely correlated
N/A
IDYA - SNDX
50%
Loosely correlated
N/A
CGON - SNDX
49%
Loosely correlated
-1.75%
ETNB - SNDX
49%
Loosely correlated
N/A
More